Engflag

Myrrh

Quick links to important sections

Myrrh

Myrrh_EN

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Myrrh

What is Myrrh? Identity, Source, and Purpose

Property Description
Active ingredient Oleoresin extract (Commiphora molmol)
Forms Tincture, Mouthwash, Topical Extract
Pharmacological class Antiseptic, Astringent Agent
General purpose Cleansing and Soothing Relief
Origin Arabian Peninsula and Eastern Africa

Defining Myrrh: Source, Classification, and Composition

Myrrh is a traditional herbal medicine defined as the aromatic gum resin obtained from the bark of trees in the Commiphora genus, primarily Commiphora molmol. It is a natural product historically recognized across multiple continents, including use in Traditional Chinese Medicine and Ayurvedic practices, validating its long-standing therapeutic acceptance. Chemically, Myrrh is an oleoresin with active constituents that include furanosesquiterpenes and various triterpenoids. Myrrh is characterized by its primary pharmacological actions as an Antiseptic and Astringent agent based on its documented traditional use.

Myrrh's Medicinal Forms and General Purpose

For therapeutic application, Myrrh is typically processed into liquid dosage forms, most commonly as an alcohol-based tincture or an aqueous solution, which are utilized for oral (referring to mucosal use in the mouth/throat) and topical administration. Its primary general purpose is to provide cleansing, protection, and soothing relief for irritated superficial tissues and mucous membranes. The tincture format is the distinguishing and effective preparation, as ethanol acts as a solvent to extract and stabilize the resinous and oily components, ensuring the active properties of the oleoresin are available. Myrrh’s capacity to support mucosal health includes the reduction of localized swelling and inflammation due to its unique chemical profile. This indicates that the medicine provides widely recognized relief by calming irritated tissues and promoting a hygienic environment for healing.

Regulatory References

  1. EMA

What side effects are possible with Myrrh?

Possible Side Effects and Safety Information

The regulatory safety profile for Myrrh (Commiphora molmol gum resin extract) is based on official government documentation detailing known adverse reactions and necessary usage constraints. The frequency of most adverse reactions is officially classified as Not Known due to limitations in available regulatory data.

Documented Adverse Reactions

The primary adverse reactions reported relate to the Skin and subcutaneous tissue disorders (dermatological system). These include localized allergic skin reactions such as contact dermatitis and general skin irritation upon application to the affected area.

Systemic effects are primarily documented in association with the oral ingestion of large doses of the gum resin (typically amounts exceeding 2–4 grams). Such high-dose exposures are associated with risks to the Gastrointestinal disorders (e.g., diarrhea), Renal and urinary disorders (kidney irritation), and Cardiac disorders (changes in heart rate).

Population-Specific Constraints

Official safety documentation defines specific constraints for vulnerable groups. Oral use is officially contraindicated during pregnancy due to the substance's documented capacity to act as a uterine stimulant. Use is not recommended during breast-feeding or for children under 12 years of age, owing to a lack of sufficient reliable safety data in these populations. Individuals with diabetes should note the substance's documented potential to affect blood sugar levels, and those using anticoagulant agents (like Warfarin) should be aware of a documented safety consequence: the potential for Myrrh to decrease the agent's effectiveness.

Overdose and Emergency Response

The official regulatory profile for Myrrh (Commiphora molmol) oleoresin tincture is defined by the absence of specific clinical data regarding acute overexposure. Governmental regulatory bodies, such as the European Medicines Agency, formally document that no case of overdose with the approved medicinal product has been reported in the literature or adverse event systems. Consequently, there are no officially documented symptoms, specific physiological manifestations, or clinical signs of overexposure listed in the regulatory prescribing information. This means the official label does not define a specific severity classification or list particular physiological systems that would be affected during an overdose.

In the event of a suspected overdose, the required action is clearly defined by regulatory mandates. Official drug documents uniformly advise that immediate action must be taken. Patients or caregivers are required to seek immediate medical attention or contact emergency services right away if overexposure is suspected. This instruction serves as the primary guidance when dealing with any potential overexposure, regardless of the lack of documented clinical manifestations. Furthermore, the regulatory labeling does not specify any particular antidotes or list required supportive management procedures, such as continuous hospital monitoring or specific protocols, for managing a Myrrh overdose.

Therapeutic Uses of Myrrh

What Myrrh Treats: Main Uses and Benefits

Myrrh is commonly used to provide symptomatic support for patients experiencing symptoms related to localized irritation. Its use is considered relevant across therapeutic domains involving historical or long-standing application as a traditional remedy.

Soothing Inflammation and Minor Ulcers in the Mouth

Myrrh is generally used to provide supportive relief for conditions presenting with symptoms related to inflammatory or irritative states in the mouth. This is applicable to addressing symptoms like tenderness, redness, and swelling associated with mild gingivitis and minor ulcers in the mouth (aphthous ulcers), and is considered relevant in situations involving general pharyngeal irritation. This provides support that may assist with easing the impact of symptoms on routine functions, helping to contribute to improved day-to-day comfort.

This is relevant in contexts involving heightened discomfort or tension from common irritations of the oral cavity.

Support for Superficial Skin Breaks and Irritation

The extract is also relevant across therapeutic domains where temporary symptomatic support is appropriate for minor external tissue damage. It is commonly used for easing the symptom burden of small, uncomplicated wounds and abrasions, as well as minor, localized boils (furuncles). Myrrh's application is generally used to provide supportive relief for the affected area and supports patients during episodes of heightened discomfort related to these superficial tissue issues.

Quick Fact

Quick Fact: Relief for Localized Discomfort

Myrrh may assist with managing symptoms that interfere with daily comfort and is commonly applied when symptoms become more noticeable in minor, non-systemic inflammatory contexts.

Eligibility and Restrictions for Use

Who Can and Cannot Use Myrrh?

Population eligibility for Myrrh gum-resin preparations is strictly defined by regulatory documents, such as the European Medicines Agency (EMA) monograph, which permits use only in specific groups. The medicine is primarily intended for adults (18 years and older) who do not have a known allergy to its components.

Contraindications and Restrictions

Population Group Eligibility Status (Regulatory Classification)
Hypersensitivity Contraindicated (known allergy to Myrrh gum-resin or excipients)
Children and Adolescents (Under 18) Not Recommended (Safety and efficacy not established)
Pregnancy and Lactation Not Recommended (Insufficient data to establish safety)
Adults (18+) Permitted (For traditional, symptomatic uses)

Myrrh is contraindicated in any patient with documented hypersensitivity to the active substance or the formulation's excipients. Furthermore, the medicine is not recommended for use in children and adolescents under 18 years of age. This restriction is based on a lack of adequate data to establish safety and efficacy in the pediatric population. Similarly, use during pregnancy and lactation is not recommended due to insufficient data concerning the safety profile in these physiological states. No specific eligibility restrictions are typically documented for patients with hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information regarding Myrrh (Commiphora myrrha) documents potential interactions with specific medicinal product categories, primarily affecting blood sugar and clotting mechanisms.

Documented Interacting Product Categories

Category Specific Example/Focus Interaction Basis Regulatory Constraint
Antidiabetes Drugs Medications for diabetes Potential to lower blood sugar levels Close monitoring of blood sugar is required
Anticoagulants Warfarin (Coumadin) May decrease the effectiveness of the drug May increase the chance of blood clotting

Interaction-Related Restrictions and Constraints

The most significant interaction constraint relates to surgical procedures. Due to its potential to interfere with blood sugar control, official guidance requires the discontinuation of Myrrh use at least 2 weeks before a scheduled surgery.

For combinations involving Antidiabetes drugs, the regulatory requirement is vigilance and close monitoring rather than outright prohibition. The use alongside Warfarin carries the constraint of potentially reducing the intended therapeutic effect of the anticoagulant. Official monographs for traditional herbal uses, such as those from the European Medicines Agency (EMA), have often specified that no interactions with other medicinal products have been reported, providing a contrasting context for traditional preparations. The overall documented profile defines two key constraints: blood sugar management and maintenance of anticoagulant efficacy.

Mechanism of Action

Dual Modulation of Nociceptive Signaling

The active components in Myrrh execute a dual-level modulation of nociceptive signaling. This is achieved centrally through agonism at opioid receptors and peripherally via the blockade of voltage-gated sodium channels in sensory nerves. This mechanistic approach interferes with the electrical signals in the nociceptive pathway, resulting in the physiological consequence of reduced nerve signal transmission and propagation.

Broad Suppression of Inflammatory Pathways

Myrrh exerts its anti-inflammatory mechanism by acting as an inhibitor on central regulatory pathways, specifically the NF-kappaB and MAPK cascades, as well as the enzyme 5-Lipoxygenase (5-LOX). By inhibiting these molecular checkpoints, the drug suppresses the cellular machinery responsible for generating pro-inflammatory mediators ( TNF-alpha, leukotrienes). This restriction on inflammatory signaling results in the physiological consequence of limiting factors that induce capillary permeability and vasodilation.

Local Surface Astringency and Microbial Control

The mechanism involves a direct, local action on the tissue surface. Resinous components precipitate surface proteins, a process known as astringency, which physically tightens the tissue and forms a protective, non-permeable layer. Simultaneously, specific constituents interfere with microbial cell function, contributing to a local barrier function against microbial surface colonization.

Dosage and Administration Information

Instruction Map: How to Use Myrrh — Administration Guidelines

The administration of Myrrh (Oleoresin extract) is defined by its application route and necessary preparation. Use is structured for two distinct local routes: oromucosal and topical (cutaneous).

Administration Scope

Category Guidance
Route of administration Oromucosal (mouth/pharynx) and Topical (skin).
Dosing schedule Oromucosal: Adults and adolescents may use 0.5 to 5 mL of the tincture per application. Topical: The tincture is applied locally to the affected skin areas.
Frequency and schedule Applied 2 to 3 times daily for direct application, or 3 times daily when used as a diluted rinse or gargle.
Preparation requirements For rinsing or gargling, the measured dose of tincture must be mixed in approximately 150 mL of water. For topical application to the skin, the tincture may be used undiluted.
Age-group administration rules Approved for use in adults and adolescents over 12 years of age. Use in children under 12 years is not recommended due to insufficient data.

Course Duration and Procedural Structure

Myrrh extract is intended for a short-term use pattern where administration is contingent on the duration of the symptoms. It is specified that if a user observes no improvement in symptoms after one week of using the medicine, the usage should be reviewed by a qualified healthcare practitioner. The preparation is designated strictly for local application to the mucosa or skin and is not intended for swallowing. This structured approach ensures the correct concentration is used for the intended application site, whether diluted for the sensitive mouth lining or applied directly to external tissues.

Recent Clinical Evidence

Research evidence / Overview of studies for Myrrh

Evidence for Use in Minor Ulcers and Inflammation in the Mouth

Research has explored Myrrh in the context of minor discomfort and irritation in the mouth, such as mild gum inflammation and small, recurrent mouth ulcers. These studies mainly consist of short-term Randomized Controlled Trials (RCTs), which is a research design that examined outcomes linked to inflammatory or irritative states.

Researchers focused on adult populations, monitoring clinical indices related to gum health. Studies also applied in research contexts involving fluctuating or unstable symptoms, such as pain intensity associated with minor ulcers. Research highlights changes measured during the study period. Studies monitored how scores for gum inflammation and bleeding evolved in the observed populations during the short observation period.

The evidence remains limited, as the research explored short-term symptom changes over very short defined time intervals. Long-term effects are not fully established, and the variability across different Myrrh formulations was observed in some studies.

Evidence for Application to Superficial Wounds and Irritation

Myrrh was studied for its supportive role when applied externally to minor skin irritations and small blemishes. Research in this area largely relies on documentation of long-standing traditional use.

To explore the traditional applications, studies monitored biological responses using pre-clinical (laboratory) models, such as animal models of wound healing. These research explored temporary physiological imbalance and examined outcomes related to tissue repair processes like re-epithelialization. Furthermore, research describes how Myrrh was evaluated in laboratory settings against various fungal and microbial organisms.

It is important to note that a definitive lack of robust, controlled human clinical trials exists for this external application. The evidence is primarily derived from laboratory settings and non-human systems. Comparative evidence is lacking to fully establish how these pre-clinical patterns translate into direct, practical outcomes for minor skin issues in humans.

Frequently Asked Questions (FAQ)

Common questions about Myrrh (FAQ)

Q: What is the difference between Myrrh essential oil, resin, and extract?

Official health products are generally standardized using the oleo-gum resin or its extract/tincture, which have defined chemical compositions for therapeutic use. Regulatory monographs do not typically provide standardized details for the pure essential oil form, which may differ in concentration and usage.

Q: Is Myrrh essential oil safe to use in a mouthwash?

Regulatory documents approve the tincture or aqueous extract form for oromucosal application (as a mouthwash or gargle). The essential oil form is generally not standardized for this use and may carry stronger warnings (e.g., for skin or ingestion) that prevent its use as an undiluted mouthwash ingredient.

Q: Are there known interactions between Myrrh and common over-the-counter pain relievers?

Official product warnings primarily focus on documented interactions with anticoagulant drugs (like Warfarin) and antidiabetes medications. No specific interactions with common over-the-counter (OTC) pain relievers are consistently documented across major regulatory sources.

Q: Does official evidence support Myrrh's effectiveness for general pain or discomfort?

Research into Myrrh’s mechanism of action shows it can interfere with the transmission of pain signals. However, clinical evidence for its use is primarily documented for pain linked to minor inflammation and ulcers in the mouth, not for general systemic pain.

Q: Is Myrrh the same botanical substance as Guggul?

According to official sources, Myrrh and Guggul are not the same botanical substances. Myrrh is sourced from Commiphora molmol or similar species, while Guggul is obtained from a different plant, Commiphora wightii.

Q: Are there different species of Myrrh used for medicinal purposes?

Yes, multiple species of Myrrh are recognized for medicinal sourcing. Official monographs typically define Myrrh as the oleo-gum resin from Commiphora molmol Engler and other closely related Commiphora species.

Q: Have studies examined Myrrh's potential effects on the immune system?

While official monographs do not list it as an approved effect, pre-clinical research has explored the possibility of Myrrh having immunomodulatory properties. These studies generally examine how Myrrh affects the expression of cell messengers and pathways related to inflammation.

Q: What is the risk level for an allergic skin reaction to topical Myrrh preparations?

Localized allergic skin reactions, such as contact dermatitis, are documented adverse reactions for Myrrh. However, regulatory sources often classify the frequency of occurrence for these reactions as Not Known due to limitations in the available data.

Q: Is it true that Myrrh may affect or increase a fever?

Official safety precautions state that Myrrh might potentially worsen a fever, and its use by individuals experiencing fever is a documented precaution.

Q: What official information exists about combining Myrrh with other herbal supplements?

The regulatory caution notes the potential for additive effects when Myrrh is combined with other herbal supplements known to lower blood sugar, which may increase the risk of low blood sugar (hypoglycemia).

Q: Does Myrrh interact with any medications used to manage high blood pressure?

Myrrh is not listed as having a primary interaction with high blood pressure medications. However, official information notes that high doses of Myrrh have been associated with changes in heart rate, and some sources suggest it may have a minor blood-pressure-lowering effect, meaning the combination with antihypertensive drugs may be a documented precaution.

Q: What is the difference in safety profile between Myrrh resin and a liquid Myrrh extract?

The general regulatory safety profile, including risks during pregnancy and high-dose effects, is based on the standardized gum-resin extract or the raw gum resin. Official product information does not typically include a direct comparison of the safety profiles between the raw resin and the processed liquid extract.

Q: Can Myrrh be used to help with symptoms of coughs or common colds?

The officially recognized uses of Myrrh are limited to local application for superficial issues like mouth or gum inflammation. While some traditional herbal systems suggest its historical use for respiratory issues, this is not an approved indication in current regulatory documents.

Q: What is the evidence regarding Myrrh having antioxidant properties?

Antioxidant properties are not listed as an official therapeutic indication. However, pharmacological research has frequently identified Myrrh's chemical constituents as possessing antioxidant qualities, which are often studied in the context of reducing cellular damage related to inflammation.

Q: What official safety information exists for using Myrrh alongside other herbs that may lower blood sugar?

Official safety information documents a caution regarding potential additive effects. Combining Myrrh with other herbal supplements known to lower blood sugar may increase the risk of developing low blood sugar (hypoglycemia).

Q: Is Myrrh known to affect how prescription pain medications work?

Pharmacological studies identify that Myrrh contains compounds that act on opioid receptors, a mechanism used by some prescription pain medications. Although Myrrh's primary interactions list does not include specific pain drugs, this mechanism suggests a potential pathway for interaction.

Q: What is the difference in application for Myrrh oil versus Myrrh tincture?

Regulatory guidelines provide clear instructions for applying the Myrrh tincture (either diluted as a rinse or undiluted topically). However, the specific, standardized application guidelines for using the pure essential oil are not defined in these official documents.

Q: Have health authorities commented on the safety of topical Myrrh for sensitive skin types?

Official safety information documents a specific precaution for individuals with sensitive skin types, noting that they are advised against using topical Myrrh products due to the documented risk of irritation and contact dermatitis.

Q: Does Myrrh have any traditional uses described for respiratory issues like asthma or congestion?

Traditional herbal medicine systems, which are sometimes referenced in official overviews, describe Myrrh's use as an expectorant and for conditions such as bronchitis or congestion. However, current regulatory approvals do not list these as official indications.

How should Myrrh be stored and disposed of?

How to Store and Dispose of Myrrh

The storage and disposal instructions for Myrrh products are mandatory requirements based on official regulatory labeling to ensure product quality and safety.

Official Storage Requirements

Requirement Type Labeled Instruction
Maximum Temperature Store below 30 C (86 F).
Environmental Protection Protect from light and moisture.
Container Rule The container must be kept tightly closed.
Child Safety Keep out of the sight and reach of children.

Disposal of Unused Product

Official labeling requires that any unused medicinal product or waste material be disposed of in accordance with local requirements. There are no specific instructions in the regulatory documents for discarding the product in household trash or down the sink, emphasizing the need to follow established pharmaceutical waste guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Myrrh found in:

A-Z Index: